The risk of infections in hematologic patients treated with rituximab is not influenced by cumulative rituximab dosage - a single center experience. [electronic resource]
Producer: 20150617Description: 364 p. digitalISSN:- 1471-2334
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Agents -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Germany
- Humans
- Immunocompromised Host
- Lymphoma, B-Cell -- drug therapy
- Male
- Middle Aged
- Prednisone -- administration & dosage
- Retrospective Studies
- Rituximab
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.